New Horizons for the Treatment of Cardiomyopathy in Children

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Collecting mono nuclear cells from the patient's blood after a course of granulocyte stimulation then injecting them into the weak heart muscle measuring the heart function at the beginning and after 2.4.6 months to assess the improvement due to this procedure, by comparing these patients to patients with the same condition treated the classic way.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Damascus University
• Treatments: Captopril; Digoxin; Furosemide

Criteria

Inclusion Criteria:

• Dilated cardiomyopathy diagnosed and treated at least 6 mo. Ago

• LVEF less than 40%

• Use of I.V inotropes

Exclusion Criteria:

• Acute infection

• Severe organ failure (other than the heart)